DcR2 Antibodies

Santa Cruz Biotechnology provides a broad selection of DcR2 monoclonal antibodies for advanced research in cell signaling and apoptosis. DcR2 monoclonal antibodies are compatible with multiple techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). DcR2, or Decoy Receptor 2, plays a critical role in regulating apoptosis by binding to death ligands, thereby inhibiting pro-apoptotic signals. This function is essential for maintaining cellular homeostasis and has implications in cancer biology, where the evasion of apoptosis is a hallmark of tumor progression. Understanding DcR2 mechanisms can provide insights into therapeutic strategies for various diseases, including cancer and autoimmune disorders. Research into DcR2 signaling pathways continues to reveal new aspects of cell death and survival mechanisms. Investigating DcR2's role in different cellular processes helps advance our understanding of disease progression and potential treatments. DcR2 expression patterns in various tissues provide valuable information about cellular responses to death signals. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific knowledge of cell death pathways and their therapeutic applications.